Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Alginic Acid Ameliorates Osteoarthritis Through FOXO3a-Dependent Regulation of the EREG-MAPK Signaling Axis.

Created on 16 Nov 2026

Authors

Ruizhou Liu, Longchi Chen, Shihan Wang, Bingqi Pan, Tianyu Zhang, Hui Chen, Xiaolei Li

Published in

Phytotherapy research : PTR. Nov 16, 2026. Epub Nov 16, 2026.

Abstract

Osteoarthritis (OA) lacks effective disease-modifying therapies. This study evaluated the therapeutic potential of alginic acid (AA), which was identified through a FOXO3a-oriented virtual screening strategy, and investigated its downstream regulatory mechanism with a focus on the EREG-MAPK signaling axis. AA was prioritized through structure-based virtual screening against FOXO3a followed by functional secondary screening. In vitro, IL-1β-stimulated human OA chondrocytes were treated with AA and assessed for extracellular matrix metabolism, inflammation, apoptosis, and MAPK pathway activity. FOXO3a knockdown and EREG-overexpression rescue experiments were performed to evaluate the functional roles of FOXO3a and EREG. In vivo, DMM-induced OA rats received intra-articular AA treatment, followed by assessment of pain behavior, cartilage pathology, and matrix preservation. Transcriptomic analysis was used to identify AA-responsive genes and signaling pathways under OA-like inflammatory conditions. AA promoted cartilage matrix synthesis, reduced matrix degradation and inflammatory responses, and attenuated chondrocyte apoptosis in vitro. In DMM-induced OA rats, AA alleviated pain hypersensitivity and reduced cartilage degeneration. Transcriptomic and subsequent validation analyses identified EREG and MAPK signaling as AA-responsive components. AA reduced EREG expression and MAPK phosphorylation. Importantly, FOXO3a knockdown markedly attenuated the effects of AA on EREG expression, p38 MAPK activation, and cartilage matrix homeostasis, supporting a functional requirement for FOXO3a in AA-mediated chondroprotection. Conversely, EREG overexpression partially counteracted the protective effects of AA. AA exerts chondroprotective effects in experimental OA and appears to act, at least in part, through FOXO3a-dependent suppression of EREG-MAPK signaling. These findings strengthen the mechanistic basis for AA as a potential OA therapeutic candidate while supporting further investigation of the FOXO3a-EREG-MAPK regulatory axis.

PMID:
43037264
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement